Pharma Mar, S.A. (0RC6.IL)
IOB - IOB Delayed price. Currency in EUR
Add to watchlist
At close: 03:51PM BST
| Previous close | 32.57 |
| Open | 32.28 |
| Bid | 31.30 x 0 |
| Ask | 32.90 x 0 |
| Day's range | 31.92 - 32.28 |
| 52-week range | 26.12 - 43.74 |
| Volume | |
| Avg. volume | 998 |
| Market cap | 580.172M |
| Beta (5Y monthly) | -0.04 |
| PE ratio (TTM) | 28.92 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.65 (2.09%) |
| Ex-dividend date | 07 June 2023 |
| 1y target est | N/A |
- PR Newswire
PharmaMar presents encouraging results at ASCO for Small Cell Lung Cancer
PharmaMar (MSE: PHM), world leader in the discovery, development and commercialization of marine-derived cancer treatments, presented data from a Phase II trial evaluating PharmaMar's lurbinectedin in combination with irinotecan in patients with relapsed Small Cell Lung Cancer (SCLC) after prior platinum-based treatment at the American Society of Clinical Oncology (ASCO) meeting, which took place from 31st May to 4th June in Chicago, United States.
© 2024 Yahoo. All rights reserved.